You are here: Home Lifelong Learning

Resources

Aldosterone-renin ratio in screening for primary aldosteronism: clinical audit

Resource type:
Audit, Event resources, Abstracts

Reduction in systolic blood pressure (SBP) with semaglutide treatment is not due to weight loss (WL) alone: data from SUSTAIN

Resource type:
Event resources, Abstracts

Referral rates of patients with diabetes to secondary care are determined by practice size and confidence in treatment, not by HbA1c level

Resource type:
Event resources, Abstracts

Home Diabetic foot ulcer service: a safe and clinically effective model for managing patients with diabetic foot ulcers in the community

Resource type:
Event resources, Abstracts

Driving improvements in inpatient diabetes care - keep your eye on the dashboard!

Resource type:
Event resources, Abstracts

Comparable glycaemic control and hypoglycaemia outcomes in adult patients with type 2 diabetes (T2D) initiating insulin glargine 300 U/mL (Gla-300) vs insulin degludec (IDeg) in real-world clinical practice: DELIVER Naïve D study

Resource type:
Event resources, Abstracts

Similar variability of fasting and 24-h self-measured plasma glucose (SMPG) with insulin glargine 300 U/mL (Gla-300) vs insulin degludec 100 U/mL (IDeg-100) in insulin- naïve adults with T2DM: the randomised BRIGHT trial

Resource type:
Event resources, Abstracts

Inpatient audit for recurrent DKA (Diabetic ketoacidocis) to highlight areas for service improvement in Warrington hospital

Resource type:
Audit, Event resources, Abstracts

Achieving glycaemic control in patients with diabetes on hemodialysis

Resource type:
Event resources, Abstracts

A good Inpatient Diabetes Service

Resource type:
JBDS Publication

ABCD and PCDS position statement on remission of type 2 diabetes

Resource type:
Position Paper

Position statement on the use of sodium-glucose cotransporter-2 inhibitors in type 1 diabetes (updated 2019)

Resource type:
Position Paper

ABCD position statement on the use of sodium-glucose cotransporter-2 inhibitors in type 1 diabetes (updated 2019)

Abstract SGLT-2 inhibitors may be increasingly used in people with type 1 diabetes as new licenses are obtained. These drugs have the potential to improve glycaemic control in people with type 1...
Resource type:
Position Paper

Hypoglycaemia

Presentation by Dr Pratik Choudhary, London​ Part of the DTN-UK Flash Glucose Monitoring Education Programme
Resource type:
Diabetes Technology Network (DTN-UK), Webinar

Bolus insulin with insulin pumps

Presentation by Dr Jackie Elliott, Sheffield​ Part of the DTN-UK Flash Glucose Monitoring Education Programme
Resource type:
Diabetes Technology Network (DTN-UK), Webinar

Fats and Protein and the Freestyle Libre

Presentation by Nicola Taylor, Dietitian, Derby​ Part of the DTN-UK Flash Glucose Monitoring Education Programme
Resource type:
Diabetes Technology Network (DTN-UK), Webinar

​Basal insulin with insulin pumps​

Presentation by Dr Emma Wilmot, Derby​ Part of the DTN-UK Flash Glucose Monitoring Education Programme
Resource type:
Diabetes Technology Network (DTN-UK), Webinar

Exercise strategies

Presentation by Dr Parth Narendran, Birmingham & Dr Rob Andrews, Exeter Part of the DTN-UK Flash Glucose Monitoring Education Programme Watch the complete Webcast 3
Resource type:
Diabetes Technology Network (DTN-UK), Webinar

Understanding arrows

Presentation by Dr Pratik Choudhary, London Part of the DTN-UK Flash Glucose Monitoring Education Programme Watch the complete Webcast 3
Resource type:
Diabetes Technology Network (DTN-UK), Webinar

Glycaemic Variability

Presentation by Dr Iain Cranston Part of the DTN-UK Flash Glucose Monitoring Education Programme Watch the complete Webcast 3
Resource type:
Diabetes Technology Network (DTN-UK), Webinar

Oral presentations of selected abstracts

Presentated at the 4th Joint Meeting of ABCD & The Renal Association on Wednesday, 13 February, 2019. Intensive medical therapy is associated with increase urinary excretion of...
Resource type:
Event resources, Abstracts, Slides

Real world data - Who gets which anti-diabetic drug in the UK and why? Do kidneys matter?

Presentated at the 4th Joint Meeting of ABCD & The Renal Association on Wednesday, 13 February, 2019 by Dr. Laurie Tomlinson, London School of Hygeine and Tropical Medicine.
Resource type:
Event resources, Slides

Neprilysin inhibition – additional benefits for cardio-renal disease in diabetes?

Presentated at the 4th Joint Meeting of ABCD & The Renal Association on Wednesday, 13 February, 2019 by Dr. Richard Haynes, University of Oxford.
Resource type:
Event resources, Slides

Post-transplantation diabetes

Presentated at the 4th Joint Meeting of ABCD & The Renal Association on Wednesday, 13 February, 2019 by Dr. Adnan Sharif, Queen Elizabeth Hospital.
Resource type:
Event resources, Slides

Outcomes from surgery for obesity in DM CKD

Presentated at the 4th Joint Meeting of ABCD & The Renal Association on Wednesday, 13 February, 2019 by Professor Carel le Roux, University College Dublin.
Resource type:
Event resources, Slides

Displaying 51 - 75 of 114 results

Information for HCPs

COVID-19 Information for Healthcare Professionals